A549 cells infected with RSV Analysis Results (GEO series: GSE147507)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HNF1A | hg19_v2_chr12_+_121416437_121416479 | 0.98 | 2.4e-02 | Click! |
HNF1B | hg19_v2_chr17_-_36105009_36105060 | -0.00 | 1.0e+00 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_-_64225508 Show fit | 12.50 |
ENST00000205948.6
|
apolipoprotein H (beta-2-glycoprotein I) |
|
chr19_-_36304201 Show fit | 11.32 |
ENST00000301175.3
|
proline dehydrogenase (oxidase) 2 |
|
chr5_+_176514413 Show fit | 9.25 |
ENST00000513166.1
|
fibroblast growth factor receptor 4 |
|
chr9_-_123812542 Show fit | 8.90 |
ENST00000223642.1
|
complement component 5 |
|
chr10_+_115312766 Show fit | 8.12 |
ENST00000351270.3
|
hyaluronan binding protein 2 |
|
chr4_+_155484103 Show fit | 7.66 |
ENST00000302068.4
|
fibrinogen beta chain |
|
chr1_+_48688357 Show fit | 7.57 |
ENST00000533824.1
ENST00000438567.2 ENST00000236495.5 ENST00000420136.2 |
solute carrier family 5 (sodium/sugar cotransporter), member 9 |
|
chr1_-_197036364 Show fit | 7.56 |
ENST00000367412.1
|
coagulation factor XIII, B polypeptide |
|
chr2_+_38177575 Show fit | 7.40 |
ENST00000407257.1
ENST00000417700.2 ENST00000234195.3 ENST00000442857.1 |
regulator of microtubule dynamics 2 |
|
chr4_+_3443614 Show fit | 7.29 |
ENST00000382774.3
ENST00000511533.1 |
HGF activator |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 21.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
3.5 | 21.1 | GO:1903412 | response to bile acid(GO:1903412) |
1.7 | 18.4 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
1.2 | 15.6 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.2 | 13.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 10.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.0 | 9.1 | GO:0045959 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
2.2 | 8.9 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 8.7 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.2 | 8.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 26.3 | GO:0030133 | transport vesicle(GO:0030133) |
1.9 | 26.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 19.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 18.1 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.7 | 12.7 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 9.1 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
1.5 | 8.9 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 8.9 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 8.4 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 7.4 | GO:0000922 | spindle pole(GO:0000922) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 21.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 18.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 14.9 | GO:0051087 | chaperone binding(GO:0051087) |
4.2 | 12.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 11.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
2.8 | 11.3 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.1 | 10.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.7 | 10.2 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.2 | 8.9 | GO:0008009 | chemokine activity(GO:0008009) |
0.9 | 8.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 31.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 20.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 18.1 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 10.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 4.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 4.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 2.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 1.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 1.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 1.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 28.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.8 | 22.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.3 | 21.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.5 | 8.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.4 | 6.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 5.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 5.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 3.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 3.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 2.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |